Roivant Sciences (NASDAQ: ROIV) insider files to sell 200,000 shares

Rhea-AI Filing Summary

Roivant Sciences Ltd. insider Eric Venker has filed a notice to sell 200,000 common shares under Rule 144. The shares are to be sold through Rockefeller Financial LLC on the NASDAQ, with an aggregate market value of about $5.3 million, versus 715,701,137 shares outstanding.

The 200,000 shares were acquired on 02/13/2026 by exercising options originally granted on 04/20/2022, with payment made by wire. Over the past three months, Venker has already sold several blocks of Roivant common shares, including 200,000 shares on 12/09/2025 for $4,169,131.30 and 200,000 shares on 01/12/2026 for $4,383,694.07.

Insights

Equity ownership and insider-transactions analyst

Insider plans another sizable share sale, but relative size looks modest.

The notice shows Eric Venker intends to sell 200,000 Roivant Sciences common shares through Rockefeller Financial on NASDAQ, with an estimated value around $5.3M. The shares come from options granted in 2022 and exercised on 02/13/2026.

Shares outstanding are 715,701,137, so this prospective block is a small fraction of the company’s equity. However, the form lists multiple prior three-month sales, each up to 200,000 shares with multi‑million‑dollar proceeds, indicating an ongoing disposition pattern by this holder.

Actual market impact will depend on how quickly these shares are sold and prevailing trading liquidity. The Rule 144 filing mainly signals potential selling activity rather than a completed transaction, and by itself does not describe any change in the company’s operations or fundamentals.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Financial LLC 45 Rockefeller Plaza Floor 5 New York NY 10111	200000	5298373.26	715701137	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	02/13/2026	Options Exercise - Grant Date 04/20/2022	Roivant Sciences Ltd.			200000	02/13/2026	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway, London X0 SW1H0DB	Common Shares	11/20/2025	7051	142923.77
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common Shares	12/09/2025	200000	4169131.30
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common Shares	01/12/2026	200000	4383694.07
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common	12/24/2025	75000	1689750.00
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common	12/23/2025	200000	4490540.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the new Form 144 filing reveal about Roivant Sciences (ROIV)?

The Form 144 shows insider Eric Venker plans to sell 200,000 Roivant Sciences common shares. These are to be sold on the NASDAQ through Rockefeller Financial LLC, with an estimated aggregate market value of about $5.3 million.

How many Roivant Sciences (ROIV) shares is the insider planning to sell?

The filing indicates a planned sale of 200,000 common shares of Roivant Sciences. The block has an aggregate market value of approximately $5,298,373.26, compared with total shares outstanding of 715,701,137 at the time referenced.

How were the Roivant Sciences (ROIV) shares in this Form 144 acquired?

The 200,000 Roivant Sciences common shares were acquired on 02/13/2026 via an option exercise from a grant originally dated 04/20/2022. Payment for the shares was made by wire transfer on the same acquisition date.

Which broker and exchange are involved in the Roivant Sciences (ROIV) planned sale?

The planned sale of 200,000 Roivant Sciences common shares will be executed through Rockefeller Financial LLC, located at 45 Rockefeller Plaza, New York. The shares are expected to be sold on the NASDAQ stock market.

Has this Roivant Sciences (ROIV) insider sold shares recently?

Yes. Over the past three months, Eric Venker has sold multiple Roivant Sciences common share blocks, including 200,000 shares on 12/09/2025 for $4,169,131.30 and another 200,000 shares on 01/12/2026 for $4,383,694.07.

How many Roivant Sciences (ROIV) shares are outstanding compared with this planned sale?

The filing lists 715,701,137 common shares outstanding for Roivant Sciences. The insider’s planned sale of 200,000 shares therefore represents only a small fraction of the total shares in circulation at that time.